Albert Duschl

Univ.-Prof. Dr. Albert Duschl is a leading academic at the University of Salzburg, heading the Duschl Research Group. He specializes in nanotoxicology, immunology, and biomedical nanotechnology. His work focuses on understanding nanoparticle interactions with biological systems, allergen-specific immunotherapy, and environmental health impacts. Key projects include PANDORA (probing nanoparticle immune responses) and NanoValid (validating nanomaterial safety).

Research interests span protein corona dynamics, allergen-nanoparticle conjugates, and aerosol toxicity. Duschl has coordinated EU-funded initiatives like NanoEIS and HUMUNITY, emphasizing translational applications in allergy therapy and nanosafety. He advises multiple PhD students and collaborates across disciplines, bridging academia, industry, and regulatory agencies.

His lab develops innovative in vitro models (e.g., NAVETTA exposure systems) and co-creates educational tools like NanoCommons for nanosafety assessment. Notable contributions include elucidating nanoparticle effects on immune cells and advancing FAIR data standards in nanotechnology research.